Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,442	2,357	1,588	3,178	1,001	475
Market Cap Growth	-9.07%	48.44%	-50.04%	217.33%	110.87%	222.46%
Enterprise Value	1,146	2,057	1,374	3,092	970	457
Last Close Price	11.40	18.61	12.50	24.97	7.95	3.77
PE Ratio	48.99	77.43	11.18	20.23	5442.54	-
Forward PE	89.18	55.42	19.45	32.20	19.55	-
PS Ratio	22.31	36.46	7.32	13.70	64.96	148.54
PB Ratio	4.26	6.96	4.36	15.49	24.08	12.10
P/TBV Ratio	4.26	6.96	4.36	15.49	24.08	12.10
P/FCF Ratio	11.50	18.80	-	17.19	279.73	-
P/OCF Ratio	11.50	18.79	-	17.18	278.25	-
EV/Sales Ratio	17.73	31.82	6.34	13.33	62.94	142.84
EV/EBITDA Ratio	51.96	93.25	7.67	15.52	-	-
EV/EBIT Ratio	52.02	93.35	7.67	15.52	-	-
EV/FCF Ratio	9.14	16.41	-	16.73	271.04	-
Net Debt / Equity Ratio	-0.87	-0.87	-0.61	-1.11	-0.97	-0.94
Net Debt / EBITDA Ratio	-13.42	-13.42	-1.24	-1.15	55.65	4.47
Net Debt / FCF Ratio	-2.36	-2.36	19.70	-1.24	-11.22	3.69
Asset Turnover	0.17	0.17	0.66	1.59	0.37	0.10
Quick Ratio	74.40	74.40	8.69	5.68	24.59	47.58
Current Ratio	76.60	76.60	8.73	5.78	25.77	49.87
Return on Equity (ROE)	8.67%	8.67%	49.92%	127.30%	0.46%	-24.57%
Return on Assets (ROA)	3.66%	3.66%	34.05%	85.52%	-1.10%	-15.83%
Return on Invested Capital (ROIC)	40.70%	18.73%	235.12%	-	-37.74%	-663.42%
Return on Capital Employed (ROCE)	6.50%	6.50%	49.20%	97.10%	-1.80%	-21.00%
Earnings Yield	2.11%	1.29%	8.95%	4.94%	0.02%	-1.64%
FCF Yield	8.69%	5.32%	-0.71%	5.82%	0.36%	-2.10%
Buyback Yield / Dilution	0.01%	0.01%	-0.01%	-1.44%	-8.76%	-10.71%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.